Tc Biopharm (holdings) PLC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
TC BioPharm reported a net loss of $3.3 million for the first quarter of 2024 and expressed substantial doubt about its ability to continue as a going concern.